Literature DB >> 10640724

Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression.

M J Pittet1, D E Speiser, D Valmori, J C Cerottini, P Romero.   

Abstract

Recent data suggest that human effector CD8+ T cells express a distinct CD27-CD45RAhigh (CD57+CD28-CD11ahigh) phenotype. Here, we propose that CTL effector function correlates better with CD56 (neuronal cell adhesion molecule (NCAM)) surface expression. CD56 was absent on cord blood CD8+ T cells, but was expressed by 4-30% of freshly isolated circulating CD8+ T cells from 15 adults. Dramatic oligoclonal expansions in 3/3 individuals were confined to the CD56+ subset of CD8+ T cells. The CD56+ subset generally contained high amounts of intracellular perforin and granzyme B. Finally, direct cytolytic capacity was closely restricted to the CD56+(CD45RAhigh) cells, better than to CD27-CD45RAhigh cells in 5/5 individuals analyzed. Thus, the phenotype corresponding to the circulating effector CD8+ T cell pool may be simplified and more precisely defined by the use of just two surface markers: CD8 and CD56.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640724     DOI: 10.4049/jimmunol.164.3.1148

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  65 in total

Review 1.  Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook.

Authors:  Richard Wu; Marie-Andrée Forget; Jessica Chacon; Chantale Bernatchez; Cara Haymaker; Jie Qing Chen; Patrick Hwu; Laszlo G Radvanyi
Journal:  Cancer J       Date:  2012 Mar-Apr       Impact factor: 3.360

2.  Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotype.

Authors:  Richard C Wu; Shujuan Liu; Jessica A Chacon; Sheng Wu; Yufeng Li; Pariya Sukhumalchandra; James L Murray; Jeffrey J Molldrem; Patrick Hwu; Hanspeter Pircher; Gregory Lizée; Laszlo G Radvanyi
Journal:  Clin Cancer Res       Date:  2012-02-03       Impact factor: 12.531

3.  Significance of unconventional peripheral CD4+CD8dim T cell subsets.

Authors:  Claude Lambert; Lambert Claude; Mohammad Ibrahim; Ibrahim Mohammad; Cristina Iobagiu; Iobagiu Cristina; Christian Genin; Genin Christian
Journal:  J Clin Immunol       Date:  2005-09       Impact factor: 8.317

4.  Reciprocal age related change in natural killer cell receptors for MHC class I.

Authors:  Charles T Lutz; Mikel B Moore; Sarah Bradley; Brent J Shelton; Susan K Lutgendorf
Journal:  Mech Ageing Dev       Date:  2005-02-19       Impact factor: 5.432

5.  CD56+ T cells inhibit HIV-1 infection of macrophages.

Authors:  Wei Hou; Li Ye; Wen-Zhe Ho
Journal:  J Leukoc Biol       Date:  2012-05-16       Impact factor: 4.962

6.  Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models.

Authors:  Denise L Crossland; Warren L Denning; Sonny Ang; Simon Olivares; Tiejuan Mi; Kirsten Switzer; Harjeet Singh; Helen Huls; Kate S Gold; Bonnie S Glisson; Laurence J Cooper; John V Heymach
Journal:  Oncogene       Date:  2018-04-06       Impact factor: 9.867

7.  Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.

Authors:  Alan A Z Alexander; Amudhan Maniar; Jean-Saville Cummings; Andrew M Hebbeler; Dan H Schulze; Brian R Gastman; C David Pauza; Scott E Strome; Andrei I Chapoval
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

8.  Umbilical cord blood T cells express multiple natural cytotoxicity receptors after IL-15 stimulation, but only NKp30 is functional.

Authors:  Qin Tang; Bartosz Grzywacz; Hongbo Wang; Nandini Kataria; Qing Cao; John E Wagner; Bruce R Blazar; Jeffrey S Miller; Michael R Verneris
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 9.  Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells.

Authors:  Elizabeth M Urban; Andrei I Chapoval; C David Pauza
Journal:  Clin Dev Immunol       Date:  2010-04-13

10.  Control of CD56 expression and tumor cell cytotoxicity in human Vgamma2Vdelta2 T cells.

Authors:  Elizabeth M Urban; Haishan Li; Cheryl Armstrong; Chiara Focaccetti; Cristiana Cairo; C David Pauza
Journal:  BMC Immunol       Date:  2009-09-21       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.